Literature DB >> 19387499

Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis.

Carlos Olano1, Carmen Méndez, José A Salas.   

Abstract

Covering: up to October 2008. Antitumor compounds produced by actinomycetes and novel derivatives generated by combinatorial biosynthesis are reviewed (with 318 references cited.) The different structural groups for which the relevant gene clusters have been isolated and characterized are reviewed, with a description of the strategies used for the generation of the novel derivatives and the activities of these compounds against tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387499     DOI: 10.1039/b822528a

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  34 in total

Review 1.  Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria.

Authors:  Beile Gao; Radhey S Gupta
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

2.  Statistical optimization and anticancer activity of a red pigment isolated from Streptomyces sp. PM4.

Authors:  Valliappan Karuppiah; Chandramohan Aarthi; Kannan Sivakumar; Lakshmanan Kannan
Journal:  Asian Pac J Trop Biomed       Date:  2013-08

Review 3.  Genomic basis for natural product biosynthetic diversity in the actinomycetes.

Authors:  Markus Nett; Haruo Ikeda; Bradley S Moore
Journal:  Nat Prod Rep       Date:  2009-09-01       Impact factor: 13.423

4.  Development of a Streptomyces venezuelae-based combinatorial biosynthetic system for the production of glycosylated derivatives of doxorubicin and its biosynthetic intermediates.

Authors:  Ah Reum Han; Je Won Park; Mi Kyeong Lee; Yeon Hee Ban; Young Ji Yoo; Eun Ji Kim; Eunji Kim; Byung-Gee Kim; Jae Kyung Sohng; Yeo Joon Yoon
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

Review 5.  Engineered polyketide biosynthesis and biocatalysis in Escherichia coli.

Authors:  Xue Gao; Peng Wang; Yi Tang
Journal:  Appl Microbiol Biotechnol       Date:  2010-09-19       Impact factor: 4.813

6.  Biosynthesis of the RNA polymerase inhibitor streptolydigin in Streptomyces lydicus: tailoring modification of 3-methyl-aspartate.

Authors:  Dina H Horna; Cristina Gómez; Carlos Olano; Martina Palomino-Schätzlein; Antonio Pineda-Lucena; Rodrigo J Carbajo; Alfredo F Braña; Carmen Méndez; José A Salas
Journal:  J Bacteriol       Date:  2011-03-11       Impact factor: 3.490

Review 7.  Antitumor compounds from marine actinomycetes.

Authors:  Carlos Olano; Carmen Méndez; José A Salas
Journal:  Mar Drugs       Date:  2009-06-11       Impact factor: 5.118

8.  Characterization of cytotoxic compound from marine sediment derived actinomycete Streptomyces avidinii strain SU4.

Authors:  S Sudha; Selvam M Masilamani
Journal:  Asian Pac J Trop Biomed       Date:  2012-10

9.  An "olivomycin A" derivative from a sponge-associated Streptomyces sp. strain SP 85.

Authors:  Mohsen Gozari; Nima Bahador; Mohammad Seddiq Mortazavi; Ebrahim Eftekhar; Amir Reza Jassbi
Journal:  3 Biotech       Date:  2019-11-07       Impact factor: 2.406

10.  Bioactivity-guided genome mining reveals the lomaiviticin biosynthetic gene cluster in Salinispora tropica.

Authors:  Roland D Kersten; Amy L Lane; Markus Nett; Taylor K S Richter; Brendan M Duggan; Pieter C Dorrestein; Bradley S Moore
Journal:  Chembiochem       Date:  2013-05-03       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.